No Data
No Data
Analysts' Top Healthcare Picks: Ikena Oncology (IKNA), PMV Pharmaceuticals (PMVP)
Ikena Oncology: Investor Caution as Dividend Payments Remain Unlikely
Ikena Oncology | 10-K: FY2024 Annual Report
Foundery Immune Studio, LLC Acquires Rights to a Suite of Next-Generation Clinical Stage Immunotherapies
Ikena Oncology (IKNA) Moves to Buy: Rationale Behind the Upgrade
William Blair Maintains Ikena Oncology(IKNA.US) With Buy Rating
SMS1313 : Good sharing![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
Jaguar8 OP : Green and Red dots because it’s Christmas![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
SMS1313 : Happy Merry Christmas brother![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
Gutarie : Merry Christmas
Fox45 : Thanks!
View more comments...